The neurofibromatosis type 1 tumor suppressor controls cell growth by regulating signal transducer and activator of transcription-3 activity in vitro and in vivo.
about
RASopathies: unraveling mechanisms with animal modelsRegulators associated with clinical outcomes revealed by DNA methylation data in breast cancer.Cucurbitacin I induces protective autophagy in glioblastoma in vitro and in vivoThe NF1 gene revisited - from bench to bedside.Regulation of circadian behavioral output via a MicroRNA-JAK/STAT circuit.Natural compounds as potential treatments of NF2-deficient schwannoma and meningioma: cucurbitacin D and goyazensolideDouble NF1 inactivation affects adrenocortical function in NF1Prx1 mice and a human patientNeurofibromatosis-1 regulates mTOR-mediated astrocyte growth and glioma formation in a TSC/Rheb-independent manner.Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP/PKA/ROCK-dependent mannerDeconvoluting mTOR biologyComprehensive establishment and characterization of orthoxenograft mouse models of malignant peripheral nerve sheath tumors for personalized medicine.Emerging insights into the molecular and cellular basis of glioblastoma.Targeted Therapy for MAPK Alterations in Pediatric Gliomas.Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.ABCG1 maintains high-grade glioma survival in vitro and in vivo.miR-107 regulates tumor progression by targeting NF1 in gastric cancer.EGFR-STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors.The ecology of brain tumors: lessons learned from neurofibromatosis-1.Glioblastoma: pathology, molecular mechanisms and markers.Contextual signaling in cancer.Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.Proteomic analysis reveals GIT1 as a novel mTOR complex component critical for mediating astrocyte survival.The STAT3-Ser/Hes3 signaling axis: an emerging regulator of endogenous regeneration and cancer growth.Ral A, via activating the mitotic checkpoint, sensitizes cells lacking a functional Nf1 to apoptosis in the absence of protein kinase C.Nature versus nurture in glioblastoma: microenvironment and genetics can both drive mesenchymal transcriptional signature.Regulation of the viability of Nf1 deficient cells by PKC isoforms.Neurofibromatosis type-1 is a prognostic indicator in human gastric carcinoma.
P2860
Q26800379-9C62A9C8-2C41-4CB5-88A7-C059E4AABE58Q30956005-C69CB431-6ABF-4525-BAEC-7FFFDEE38659Q33675791-0C7523B4-A75D-457F-82D3-1B7D00A17790Q34227509-4371CE4F-9BCC-4FDA-A91C-CA5B53D1D7C4Q34251948-A7EEF45E-509C-4171-A56F-51DEC5BBE3AEQ35100322-36A4189E-ACFD-46A8-A679-F2345A613753Q35182111-D6505E28-1B77-495C-9641-10D5AF00BA31Q35229380-B01F2A26-BBF8-4BC6-A411-0E97B0EBECF4Q35613659-2BB3BA1B-4E2B-4908-83C5-DF642CDA694AQ35801388-40F0CD4C-B17E-4962-9232-0B7A918AEE28Q35822579-D04E5242-9D65-43A7-AB20-E3EDDBA34875Q35914897-6E7E490F-C1D4-49A8-8A54-A1F85A3CA596Q36233325-35A6739A-587C-4F12-877B-F7EFFEB3F502Q36663582-7CA44D60-D671-4BE7-AEC4-A62D3F499B46Q37269034-41B3877B-2E3D-40A3-BA4B-5914EFEF93FCQ37402573-B96BA71A-5FB9-47FE-8322-ABA0DB13CC07Q37582297-7F6CC97B-2F66-4E09-B01A-5912531075DDQ37809458-3D317239-F813-45B2-A0E5-A8AF34295CF2Q38460865-F7FDFB68-8F6E-4B4F-822E-0C6ACD53D6B0Q38857220-E1DA6043-9AAF-40C3-ACE6-4D27CA80705DQ39610409-9853DA01-78A5-405D-9FDF-ADFC68685466Q39658084-9D9E0211-CBF6-490A-A2EE-0A0AD4C59E92Q41848212-8F8A2AA6-62F3-49F0-9B86-EB50F5C45F67Q42055537-282A1EB8-D0D0-48CE-B196-A74B8FD95C7CQ42098238-F20ED6B4-2A4F-4735-BDAD-407699D4E5ADQ42208455-E622C10D-E0EB-4207-9F2D-C151E062ACEDQ47172712-F0603A15-C90A-4249-8D18-688174CCEB20
P2860
The neurofibromatosis type 1 tumor suppressor controls cell growth by regulating signal transducer and activator of transcription-3 activity in vitro and in vivo.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
The neurofibromatosis type 1 t ...... activity in vitro and in vivo.
@en
The neurofibromatosis type 1 t ...... activity in vitro and in vivo.
@nl
type
label
The neurofibromatosis type 1 t ...... activity in vitro and in vivo.
@en
The neurofibromatosis type 1 t ...... activity in vitro and in vivo.
@nl
prefLabel
The neurofibromatosis type 1 t ...... activity in vitro and in vivo.
@en
The neurofibromatosis type 1 t ...... activity in vitro and in vivo.
@nl
P2093
P2860
P1433
P1476
The neurofibromatosis type 1 t ...... activity in vitro and in vivo
@en
P2093
David R Piwnica-Worms
Fausto J Rodriguez
Jonathan N Byrd
Karlyne M Reilly
Robert G Tuskan
Scott E Harpstrite
Scott M Gianino
Sutapa Banerjee
P2860
P304
P356
10.1158/0008-5472.CAN-09-2178
P407
P577
2010-02-02T00:00:00Z